These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26852277)

  • 21. A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells--using rifampicin as an example.
    Clewe O; Goutelle S; Conte JE; Simonsson US
    Eur J Clin Pharmacol; 2015 Mar; 71(3):313-9. PubMed ID: 25620089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.
    Yoshizawa K; Ikawa K; Ikeda K; Ohge H; Morikawa N
    Pediatr Infect Dis J; 2013 Nov; 32(11):1208-16. PubMed ID: 23676856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.
    Lodise TP; Gotfried M; Barriere S; Drusano GL
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2300-4. PubMed ID: 18426898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia.
    Dimopoulos G; Almyroudi MP; Kapralos I; Apostolopoulou O; Flevari A; Nicolau DP; Dokoumetzidis A
    Int J Antimicrob Agents; 2022 Jan; 59(1):106487. PubMed ID: 34843925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and Pharmacodynamic Analysis of Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Imipenem.
    Li Z; Bai J; Wen A; Shen S; Duan M; Li X
    Clin Ther; 2020 Aug; 42(8):1564-1577.e8. PubMed ID: 32741646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zanamivir pharmacokinetics and pulmonary penetration into epithelial lining fluid following intravenous or oral inhaled administration to healthy adult subjects.
    Shelton MJ; Lovern M; Ng-Cashin J; Jones L; Gould E; Gauvin J; Rodvold KA
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5178-84. PubMed ID: 21896909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
    Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 May; 56(5):2627-34. PubMed ID: 22330925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers.
    Brandsma J; Goss VM; Yang X; Bakke PS; Caruso M; Chanez P; Dahlén SE; Fowler SJ; Horvath I; Krug N; Montuschi P; Sanak M; Sandström T; Shaw DE; Chung KF; Singer F; Fleming LJ; Sousa AR; Pandis I; Bansal AT; Sterk PJ; Djukanović R; Postle AD;
    Metabolomics; 2018 Sep; 14(10):123. PubMed ID: 30830396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae.
    Ong CT; Dandekar PK; Sutherland C; Nightingale CH; Nicolau DP
    Chemotherapy; 2005 Oct; 51(6):339-46. PubMed ID: 16224186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
    Chandorkar G; Huntington JA; Gotfried MH; Rodvold KA; Umeh O
    J Antimicrob Chemother; 2012 Oct; 67(10):2463-9. PubMed ID: 22773741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of imipenem in burn patients.
    Dailly E; Kergueris MF; Pannier M; Jolliet P; Bourin M
    Fundam Clin Pharmacol; 2003 Dec; 17(6):645-50. PubMed ID: 15015709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation Solution.
    Lakota EA; Sato N; Koresawa T; Kondo K; Bhavnani SM; Ambrose PG; Rubino CM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining Fluid.
    Välitalo PA; Griffioen K; Rizk ML; Visser SA; Danhof M; Rao G; van der Graaf PH; van Hasselt JG
    Pharm Res; 2016 Apr; 33(4):856-67. PubMed ID: 26626793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer.
    Gupta A; Jarzab B; Capdevila J; Shumaker R; Hussein Z
    Br J Clin Pharmacol; 2016 Jun; 81(6):1124-33. PubMed ID: 26879594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population Pharmacokinetics of Total and Free Erdafitinib in Adult Healthy Volunteers and Cancer Patients: Analysis of Phase 1 and Phase 2 Studies.
    Dosne AG; Valade E; Stuyckens K; Li LY; Ouellet D; Perez-Ruixo JJ
    J Clin Pharmacol; 2020 Apr; 60(4):515-527. PubMed ID: 31742712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelled Target Attainment after Temocillin Treatment in Severe Pneumonia: Systemic and Epithelial Lining Fluid Pharmacokinetics of Continuous versus Intermittent Infusions.
    Layios N; Visée C; Mistretta V; Denooz R; Maes N; Descy J; Frippiat F; Marchand S; Grégoire N
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0205221. PubMed ID: 35099273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.
    Muller-Serieys C; Bancal C; Dombret MC; Soler P; Murciano G; Aubier M; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2099-103. PubMed ID: 1444291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.
    Lodise TP; Kinzig-Schippers M; Drusano GL; Loos U; Vogel F; Bulitta J; Hinder M; Sörgel F
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1945-51. PubMed ID: 17485507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.
    Yang S; Lukey P; Beerahee M; Hoke F
    Clin Pharmacokinet; 2013 Mar; 52(3):187-98. PubMed ID: 23254770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.